Nicole E Scangarella-Oman (Nicole Scangarella-Oman)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Escherichia Coli

Urinary Tract Infection

Multidrug Resistant

Men Who Have Sex With Men

Top Venues

Infectious diseases and therapy

Antimicrobial agents and chemotherapy

Emerging microbes & infections

Sexually transmitted infections

This page only lists publications with an associated author ORCID identifier.

Publications

Keith S Kaye, Vikas Gupta, Aruni Mulgirigama, Ashish V Joshi, Nicole E Scangarella-Oman, Kalvin Yu, Janet Watts, Fanny S Mitrani-Gold
Co-resistance Among Escherichia coli and Klebsiella pneumoniae Urine Isolates from Female Outpatients with Presumed UTI: A Retrospective US Cohort Study. Infectious diseases and therapy 13 (7) (2024)
Keith S Kaye, Vikas Gupta, Aruni Mulgirigama, Ashish V Joshi, Nicole E Scangarella-Oman, Kalvin Yu, Janet Watts, Fanny S Mitrani-Gold
Co-resistance Among Escherichia coli and Klebsiella pneumoniae Urine Isolates from Female Outpatients with Presumed UTI: A Retrospective US Cohort Study. Infectious diseases and therapy 13 (7) (2024)
Keith S Kaye, Vikas Gupta, Aruni Mulgirigama, Ashish V Joshi, Nicole E Scangarella-Oman, Kalvin Yu, Janet Watts, Fanny S Mitrani-Gold
Co-resistance Among Escherichia coli and Klebsiella pneumoniae Urine Isolates from Female Outpatients with Presumed UTI: A Retrospective US Cohort Study. Infectious diseases and therapy (2024)
Keith S Kaye, Vikas Gupta, Aruni Mulgirigama, Ashish V Joshi, Nicole E Scangarella-Oman, Kalvin Yu, Janet Watts, Fanny S Mitrani-Gold
Co-resistance Among Escherichia coli and Klebsiella pneumoniae Urine Isolates from Female Outpatients with Presumed UTI: A Retrospective US Cohort Study. Infectious diseases and therapy 13 (7) (2024)
Keith S Kaye, Vikas Gupta, Aruni Mulgirigama, Ashish V Joshi, Nicole E Scangarella-Oman, Kalvin Yu, Janet Watts, Fanny S Mitrani-Gold
Co-resistance Among Escherichia coli and Klebsiella pneumoniae Urine Isolates from Female Outpatients with Presumed UTI: A Retrospective US Cohort Study. Infectious diseases and therapy 13 (7) (2024)
Keith S Kaye, Vikas Gupta, Aruni Mulgirigama, Ashish V Joshi, Nicole E Scangarella-Oman, Kalvin Yu, Janet Watts, Fanny S Mitrani-Gold
Co-resistance Among Escherichia coli and Klebsiella pneumoniae Urine Isolates from Female Outpatients with Presumed UTI: A Retrospective US Cohort Study. Infectious diseases and therapy 13 (7) (2024)
Caroline R Perry, Nicole E Scangarella-Oman, Helen Millns, William G Flight, Sally Gatsi, Charles Jakielaszek, Salim Janmohamed, David A Lewis
Efficacy and Safety of Gepotidacin as Treatment of Uncomplicated Urogenital Gonorrhea (EAGLE-1): Design of a Randomized, Comparator-Controlled, Phase 3 Study. Infectious diseases and therapy (2023)
S J Ryan Arends, Deborah Butler, Nicole E Scangarella-Oman, Mariana Castanheira, Rodrigo Elisandro Mendes
Antimicrobial Activity of Gepotidacin Tested against Escherichia coli and Staphylococcus saprophyticus Isolates Causing Urinary Tract Infections in Medical Centers Worldwide (2019 to 2020). Antimicrobial agents and chemotherapy (2023)
Nicole E Scangarella-Oman, Mohammad Hossain, Jennifer L Hoover, Caroline R Perry, Courtney Tiffany, Aline Barth, Etienne F Dumont
Dose Selection for Phase III Clinical Evaluation of Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections. Antimicrobial agents and chemotherapy 66 (3) (2022)
Nicole E Scangarella-Oman, Mohammad Hossain, Caroline R Perry, Courtney Tiffany, Marcy Powell, Brandon Swift, Etienne F Dumont
Dose selection for a phase III study evaluating gepotidacin (GSK2140944) in the treatment of uncomplicated urogenital gonorrhoea. Sexually transmitted infections (2022)
Brian D VanScoy, Elizabeth A Lakota, Haley Conde, Steven Fikes, Sujata M Bhavnani, Philippa B Elefante, Nicole E Scangarella-Oman, Paul G Ambrose
Gepotidacin Pharmacokinetics-Pharmacodynamics against Escherichia coli in the One-Compartment and Hollow-Fiber In Vitro Infection Model Systems. Antimicrobial agents and chemotherapy 65 (12) (2021)
Jorgen Skov Jensen, Christina Nørgaard, Nicole E Scangarella-Oman, Magnus Unemo
In vitro activity of the first-in-class triazaacenaphthylene gepotidacin alone and in combination with doxycycline against drug-resistant and -susceptible Mycoplasma genitalium. Emerging microbes & infections 9 (1) (2021)
Meredith A Hackel, James A Karlowsky, Michele A Canino, Daniel F Sahm, Nicole E Scangarella-Oman
In Vitro Activity of Gepotidacin against Gram-Negative and Gram-Positive Anaerobes. Antimicrobial agents and chemotherapy 66 (2) (2021)
Brian D VanScoy, Nicole E Scangarella-Oman, Steven Fikes, Sharon Min, Jianzhong Huang, Karen Ingraham, Sujata M Bhavnani, Haley Conde, Paul G Ambrose
Relationship between Gepotidacin Exposure and Prevention of On-Therapy Resistance Amplification in a Neisseria gonorrhoeae Hollow-Fiber In Vitro Infection Model. Antimicrobial agents and chemotherapy 64 (10) (2020)